Chemcon Speciality rallies after Q1 PAT climbs 90% YoY

Image
Capital Market
Last Updated : Aug 10 2022 | 5:31 PM IST

Chemcon Speciality Chemicals surged 16.80% to Rs 386.85 after the company's net profit rose 89.9% to Rs 25.46 crore on 56.3% increase in net sales to Rs 89.41 crore in Q1 June 2022 over Q1 June 2021.

Profit before tax (PBT) jumped 89% year-on-year to Rs 34.14 crore in Q1 June 2022. EBITDA rose 87.8% to Rs 33.6 crore in Q1 FY23 as against Rs 17.9 crore in Q1 FY22. EBITDA margin stood at Rs 37.5% in Q1 FY23 as against 31.2% in Q1 FY22.

Total expense climbed 42% YoY to Rs 55.86 crore in Q1 FY23. Cost of raw material consumed stood at Rs 45.58 crore (up 67.4% YoY) and employee expenses stood at Rs 5.64 crore (up 32.1% YoY).

The company's revenue from the domestic business stood at 53% while revenue from exports was at 47%. Production volume jumped to 2,051 MTPA in Q1 FY23 as against 1,883 MTPA in Q4 FY22 and 1,428 in Q1 FY22 .

Kamal Aggarwal, chairman & MD said, "We are delighted to report the highest ever quarterly performance led by healthy demand across the product portfolio. Both HMDS and CMIC are gaining traction and are currently performing satisfactorily. CMIC's newly expanded capacity is also contributing to the growth, and production is expected to ramp up in the coming quarters. On the other hand, the Bromide chemicals have recorded a strong performance on the back of a high-order book. We anticipate consistent performance from these chemicals in the coming months.

Commercial production of P9 unit is expected to commercialize by end of Q2FY23 whereas we are targeting P10 unit to commence by end of this financial year. Post expansion program, we will be well prepared to arrest the upcoming opportunities not only for existing products but also for new products. Some of the new products which we are targeting are primarily imported substitutions."

The company's board approved an interim dividend of Rs 4 per share for the FY 2022-23.

Chemcon Speciality Chemicals is a leading manufacturer of specialized chemicals, such as Hexamethyldisilazane ("HMDS"), Chloromethyl Isopropyl Carbonate ("CMIC") and inorganic bromides.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Subscribe to Business Standard digital and get complimentary access to The New York Times

Quarterly Starter

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

Save 46%

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Access to Exclusive Premium Stories Online

  • Over 30 behind the paywall stories daily, handpicked by our editors for subscribers

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Aug 10 2022 | 10:32 AM IST

Next Story